Literature DB >> 17680194

Large intrathecal volume: a cause of true failed spinal anesthesia.

Joan E Spiegel1, Philip Hess.   

Abstract

A 37-year-old woman scheduled for postpartum tubal ligation received two intrathecal doses of 2% hyperbaric mepivacaine (44 mg and 40 mg) and a subsequent single dose of 5% hyperbaric lidocaine (62.5 mg). Her sensory level never extended beyond S1. She subsequently underwent an uneventful general anesthetic, and had no residual sensory or motor deficits. An examination of the patient's lumbosacral magnetic resonance imaging (MRI) scan revealed an unusually large thecal volume. A large lumbosacral intrathecal volume may result in significant dilution or poor redistribution of hyperbaric local anesthetic. The final sensory level may be reduced or absent as a result. Intrathecal volume may be the most important non-modifiable factor affecting intrathecal distribution of local anesthetics; however, it cannot be easily measured or predicted. True failed spinal anesthesia should be distinguished from technical mishap, i.e., failing to introduce the anesthetic into the intrathecal space. The differential of a truly failed single-injection spinal anesthetic may include a large thecal volume, dural ectasias, cysts, and simple anatomic sacral restriction. To minimize maldistribution and neurotoxicity, the sum dose of all intrathecal local anesthetics administered for a single procedure should not significantly exceed the maximum recommended single-dose amount.

Entities:  

Mesh:

Year:  2007        PMID: 17680194     DOI: 10.1007/s00540-007-0510-5

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  18 in total

Review 1.  Local anesthetic neurotoxicity: clinical injury and strategies that may minimize risk.

Authors:  Kenneth Drasner
Journal:  Reg Anesth Pain Med       Date:  2002 Nov-Dec       Impact factor: 6.288

2.  Distribution of catheter-injected local anesthetic in a model of the subarachnoid space.

Authors:  M L Rigler; K Drasner
Journal:  Anesthesiology       Date:  1991-10       Impact factor: 7.892

3.  Lumbosacral cerebrospinal fluid volume is the primary determinant of sensory block extent and duration during spinal anesthesia.

Authors:  R L Carpenter; Q H Hogan; S S Liu; B Crane; J Moore
Journal:  Anesthesiology       Date:  1998-07       Impact factor: 7.892

4.  Neurologic symptom associated with a repeated injection after failed spinal anesthesia.

Authors:  Y Hirabayashi; R Konishi; R Shimizu
Journal:  Anesthesiology       Date:  1998-11       Impact factor: 7.892

Review 5.  Distribution of local anesthetic solutions within the subarachnoid space.

Authors:  N M Greene
Journal:  Anesth Analg       Date:  1985-07       Impact factor: 5.108

6.  The anesthetic and recovery profile of two doses (60 and 80 mg) of plain mepivacaine for ambulatory spinal anesthesia.

Authors:  J Pawlowski; R Sukhani; A L Pappas; K M Kim; J Lurie; H Gunnerson; A Corsino; K Frey; P Tonino
Journal:  Anesth Analg       Date:  2000-09       Impact factor: 5.108

7.  A series of truly failed spinal anesthetics.

Authors:  S I Schmidt; S S Moorthy; S F Dierdorf; J M Anagnostou
Journal:  J Clin Anesth       Date:  1990 Sep-Oct       Impact factor: 9.452

8.  Incidence and etiology of failed spinal anesthetics in a university hospital: a prospective study.

Authors:  R J Munhall; R Sukhani; A P Winnie
Journal:  Anesth Analg       Date:  1988-09       Impact factor: 5.108

9.  Cauda equina syndrome after continuous spinal anesthesia.

Authors:  M L Rigler; K Drasner; T C Krejcie; S J Yelich; F T Scholnick; J DeFontes; D Bohner
Journal:  Anesth Analg       Date:  1991-03       Impact factor: 5.108

10.  Local anesthetic resistance in a pregnant patient with lumbosacral plexopathy.

Authors:  Renae Kavlock; Paul H Ting
Journal:  BMC Anesthesiol       Date:  2004-01-16       Impact factor: 2.217

View more
  1 in total

1.  Failure of spinal anesthesia with marcaine (bupivacaine): recent cluster of cases.

Authors:  Marianne J Nagata
Journal:  Can J Hosp Pharm       Date:  2009-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.